⌘K
t
Judges Scientific plc announced that Non-Executive Director Charles Holroyd purchased 524 ordinary shares on 24 July 2025. The shares were acquired at a price of 6675 pence per share. Following this transaction, Charles Holroyd's beneficial holding is 7,747 Ordinary Shares, representing approximately 0.12% of the company's total issued share capital.
| Date | 25 Jul 2025 |
| Time | 10:07:41 |
| Category | Director/PDMR dealings |
| ID | 6167S |
Judges Scientific plc
Director/PDMR Shareholding
Judges Scientific plc (AIM: JDG), a group focused on acquiring and developing companies in the scientific instrument sector announces that Charles Holroyd, Non-Executive Director, on 24 July 2025 purchased 524 ordinary shares of 5p each in the Company ("Ordinary Shares") at a price of 6675 pence per share. Following this transaction Charles Holroyd's beneficial holding is now 7,747 Ordinary Shares representing approximately 0.12% of the total issued share capital and voting rights in the Company. Full details of which are set out below:
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
|
a)
|
Name
|
Charles Holroyd |
||||
|
2
|
Reason for the notification
|
|||||
|
a)
|
Position/status
|
Non-Executive Director |
||||
|
b)
|
Initial notification /Amendment
|
Initial notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
|
a)
|
Name
|
Judges Scientific plc |
||||
|
b)
|
LEI
|
2138004EXWWPTW1JOL31 |
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary Shares in Judges Scientific plc
GB0032398678
|
||||
|
b)
|
Nature of the transaction
|
Purchase of Ordinary Shares |
||||
|
c)
|
Price(s) and volume(s)
|
|
||||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A (single transaction) |
||||
|
e)
|
Date of the transaction
|
24/7/25 |
||||
|
f)
|
Place of the transaction
|
London Stock Exchange, AIM Market (XLON) |
||||
|
For further information please contact:
|
|
||
|
Judges Scientific plc David Cicurel, CEO Brad Ormsby, CFO Tel: +44 (0) 20 3829 6970
|
Shore Capital (Nominated Adviser & Joint Broker) Stephane Auton Harry Davies-Ball Tel: +44 (0) 20 7408 4090
|
|
|
|
Panmure Liberum (Joint Broker) Edward Mansfield Nikhil Varghese Tel : +44 (0) 20 3100 2222
|
Investec Bank plc (Joint Broker) Virginia Bull Carlton Nelson Tel: +44 (0) 20 7597 4000 |
|
|
|
Alma (Financial Public Relations) Sam Modlin Rebecca Sanders-Hewett Joe Pederzolli Sarah Peters Tel: +44 (0) 20 3405 0205 |
|
|
|
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 25 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.
For further information, please visit www.judges.uk.com